These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 15331189)

  • 1. Pulmonary sarcoidosis.
    Baughman RP
    Clin Chest Med; 2004 Sep; 25(3):521-30, vi. PubMed ID: 15331189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Successful treatment with infliximab of a patient with refractory sarcoidosis].
    Fouchier SM; Möller GM; Van Santen-Hoeufft M; Faber CG; Smeenk FW; Drent M
    Ned Tijdschr Geneeskd; 2004 Dec; 148(49):2446-50. PubMed ID: 15626311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Up-to-date in pulmonary and extrapulmonary sarcoidosis.
    Valeyre D; Uzunhan Y; Bouvry D; Naccache JM; Nunes H
    Acta Clin Belg; 2008; 63(6):408-13. PubMed ID: 19170359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infliximab therapy in pulmonary sarcoidosis.
    Kähler CM; Heininger P; Loeffler-Ragg J; Vogelsinger H
    Am J Respir Crit Care Med; 2007 Aug; 176(4):417; author reply 417-8. PubMed ID: 17675452
    [No Abstract]   [Full Text] [Related]  

  • 5. Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement.
    Baughman RP; Drent M; Kavuru M; Judson MA; Costabel U; du Bois R; Albera C; Brutsche M; Davis G; Donohue JF; Müller-Quernheim J; Schlenker-Herceg R; Flavin S; Lo KH; Oemar B; Barnathan ES;
    Am J Respir Crit Care Med; 2006 Oct; 174(7):795-802. PubMed ID: 16840744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infliximab for treating sarcoidosis patients, Portuguese experience.
    Aguiar M; Marçal N; Mendes AC; Bugalho de Almeida A
    Rev Port Pneumol; 2011; 17(2):85-93. PubMed ID: 21477572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does tumour necrosis factor-alpha inhibitor infliximab induce histological resolution of pulmonary sarcoid granulomas?
    Milman N; Andersen CB; Baslund B; Loft A; Iversen M
    Clin Respir J; 2007 Dec; 1(2):106-13. PubMed ID: 20298289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 18F-FDG PET in sarcoidosis: an observational study in 12 patients treated with infliximab.
    Keijsers RG; Verzijlbergen JF; van Diepen DM; van den Bosch JM; Grutters JC
    Sarcoidosis Vasc Diffuse Lung Dis; 2008 Dec; 25(2):143-9. PubMed ID: 19382534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pulmonary and renal involvement in a TNFα antagonist drug-induced sarcoidosis].
    Olivier A; Gilson B; Lafontaine S; Pautot JX; Bindi P
    Rev Med Interne; 2012 May; 33(5):e25-7. PubMed ID: 21592629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comment to the article: infliximab for treating sarcoidosis patients, Portuguese experience.
    Morais A
    Rev Port Pneumol; 2011; 17(2):94-5. PubMed ID: 21477573
    [No Abstract]   [Full Text] [Related]  

  • 11. [Sarcoidosis (Boeck's disease). Inflammatory granulomatous systemic disease which involves especially the lung and lymph nodes].
    Pabst S; Vetter H; Grohé Ch
    Praxis (Bern 1994); 2004 Oct; 93(42):1717-22; quiz 1723-4. PubMed ID: 15529958
    [No Abstract]   [Full Text] [Related]  

  • 12. Infliximab in sarcoidosis: more answers or more questions?
    White ES
    Am J Respir Crit Care Med; 2006 Oct; 174(7):732-3. PubMed ID: 16988163
    [No Abstract]   [Full Text] [Related]  

  • 13. Long term follow-up of infliximab efficacy in pulmonary and extra-pulmonary sarcoidosis refractory to conventional therapy.
    Russell E; Luk F; Manocha S; Ho T; O'Connor C; Hussain H
    Semin Arthritis Rheum; 2013 Aug; 43(1):119-24. PubMed ID: 23332903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [TNFα blocking agents and sarcoidosis: an update].
    Toussirot E; Pertuiset E
    Rev Med Interne; 2010 Dec; 31(12):828-37. PubMed ID: 20510487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lung caverns in sarcoidosis with nodular liver and spleen involvement].
    Brader P; Scheidl S; Reittner P
    Rofo; 2004 Oct; 176(10):1515-7. PubMed ID: 15383990
    [No Abstract]   [Full Text] [Related]  

  • 16. The use of infliximab in cutaneous sarcoidosis.
    Meyerle JH; Shorr A
    J Drugs Dermatol; 2003 Aug; 2(4):413-4. PubMed ID: 12884466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blinded, randomized, placebo-controlled trial of infliximab in subjects with active pulmonary sarcoidosis.
    Rossman MD; Newman LS; Baughman RP; Teirstein A; Weinberger SE; Miller W; Sands BE
    Sarcoidosis Vasc Diffuse Lung Dis; 2006 Oct; 23(3):201-8. PubMed ID: 18038919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary Sarcoidosis Induced by Anti-Tumor Necrosis Factor Therapy: A Paradoxical Effect.
    Aliel Vigano Pugliesi A; Zerbini Mariano R; Matsunaga De Angelis C; Barros Bertolo M; Alexandre Yazbek M
    J Clin Rheumatol; 2020 Jan; 26(1):23-24. PubMed ID: 29667945
    [No Abstract]   [Full Text] [Related]  

  • 19. [Infliximab treatment for chronic sarcoidosis--a case series].
    Jounieaux F; Chapelon C; Valeyre D; Israel Biet D; Cottin V; Tazi A; Fournier E; Wallaert B;
    Rev Mal Respir; 2010 Sep; 27(7):685-92. PubMed ID: 20863968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beneficial effect of infliximab on refractory sarcoidosis.
    Ørum M; Hilberg O; Krag S; Bendstrup E
    Dan Med J; 2012 Dec; 59(12):A4535. PubMed ID: 23290282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.